|
|
|
| Industry update |
| //Valo Therapeutics (Oxford, UK and Helsinki, Finland) appointed to its Board biotech entrepreneur and immunotherapy developer, Dr. Mai-Britt Zocca.
//Following the retirement of Tony Brampton, Eddy Littler has been appointed as non-executive Chairman of Domainex (Cambridge, UK).
//After 13 years leading the company, Peter Rosholm has decided to step down as CEO of Albumedix (Nottingham, UK). The company’s Chief Operating Officer, Jonas Skjødt, will take over as CEO, effective 1 July, 2020.
//Amphista Therapeutics (Gladsgow, UK) announced the appointment of Dr. Ian Churcher as Chief Scientific Officer.
//Galecto (Boston, MA, and Copenhagen, Denmark) a privately held biotechnology company focused on the development of novel treatments for fibrosis and cancer, announced Amit Munshi as its new Chairman. The company also announced the appointment of David Shapiro M.D., former Chief Medical Officer of Intercept Pharmaceuticals, to its Board of Directors.
|
|
|
|
|
|
|
|
|
 |
|
Pharma CEO Leadership During the Pandemic |
A recent roundtable of pharma CEOs, moderated by Dr. Scott Gottlieb, discussed concerns around COVID-19, including clinical trials, product launches, keeping employees safe and the industry's future
… Read more |
|
|
|
|
| Audio |
 |
|
|
|
|
|
